Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page displays the clinical-trial record for Tempol in COVID-19 patients, including its terminated status, study design, eligibility criteria, locations, and outcome measures.SummaryDifference52%

- Check20 days agoChange DetectedThe footer revision indicator changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.7.0 was added to the page, indicating a new site revision. This update does not modify the study data or user-facing content.SummaryDifference18%

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.